The global injectable drug delivery devices market size is expected to grow from $34.49 billion in 2021 to $38.03 billion in 2022 at a compound annual growth rate (CAGR) of 10.3%. The global injectable drug delivery market size is then expected to grow to $55.89 billion in 2026 at a CAGR of 10.1%.
What is the Global Injectable Drug Delivery Devices Market?
The injectable drug delivery devices market consists of sales of conventional syringes, needle-free injectors, auto-injectors, and pen injectors. These are used for various routes of drug administration, such as intravenous, subcutaneous, intradermal, intraperitoneal, and intramuscular, and others to treat medical conditions ranging from cancer to autoimmune disorders.
Get a Sample of the global injectable drug delivery devices market report
https://www.thebusinessresearchcompany.com/sample.aspx?id=2835&type=smp
What drives the Global Injectable Drug Delivery Devices Market?
The increasing preference for self-injection devices is driving the injectable drug delivery devices market. Self-injection devices are medical devices that can be used by the patient in-home setting for self-administration of the medication. Self-injection devices include needle-free, auto, pen, and wearable injectors. These self-injectables were developed to provide the most adaptable device which has a high precision of drug delivery and is easy to use. In addition, with the innovations in self-injectable devices, the acceptance of these products has increased over the past few years. BD Physioject is a disposable auto-injector, manufactured by Becton, Dickinson, and Company, which is clinically proven, reliable, and cost-effective specifically designed for self-injection of drugs by patients suffering from chronic diseases, including rheumatoid arthritis, multiple sclerosis, asthma, and osteoporosis. The other companies currently involved in the self-injections market include Abbvie, Inc., 3M, Baxter, Gerresheimer AG, Pfizer Inc, and more. The advantages of self-injectable injections and increasing awareness of self-administration have increased the demand for self-injectable devices and will drive the injectable drug delivery devices market during the forecast period.
Get the full global injectable drug delivery devices industry report here
https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report
Global Injectable Drug Delivery Devices Market Segments
The global injectable drug delivery devices market is segmented:
By Type: Conventional Injectable, Prefilled Syringes, Auto-Injectors, Pen-Injectors
By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Others
By End-User: Hospitals and Clinics, Home Healthcare Settings, Pharmaceutical and Biotechnological Companies, Research Laboratories, Others
By Geography: The regions covered in the injectable drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Injectable Drug Delivery Devices Global Market Report 2022provides market size and growth forecasts for the global injectable drug delivery devices market, global injectable drug delivery devices market share, injectable drug delivery devices market segments and geographies, injectable drug delivery devices market competitive landscape including leading competitors’ revenues, profiles and market shares. The injectable drug delivery devices market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Injectable Drug Delivery Devices Industry Playersinclude Becton, Dickinson and Company, Gerresheimer AG, Eli Lilly and Company, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Schott AG, Baxter International, Owen Mumford, Mylan N.V., and Sanofi. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.
